CD34 selected cells for the treatment of poor graft function after allogeneic stem cell transplantation

scientific article published on 24 May 2014

CD34 selected cells for the treatment of poor graft function after allogeneic stem cell transplantation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BBMT.2014.05.016
P698PubMed publication ID24862637

P50authorFederica GalavernaQ57046114
Riccardo VaraldoQ84914791
P2093author name stringFrancesca Gualandi
Andrea Bacigalupo
Maria Teresa Van Lint
Sarah Pozzi
Silvia Luchetti
Anna Maria Raiola
Carmen di Grazia
Teresa Lamparelli
Stefania Bregante
Alessandra Stasia
Anna Ghiso
P433issue9
P304page(s)1440-1443
P577publication date2014-05-24
P1433published inBiology of Blood and Marrow TransplantationQ15754328
P1476titleCD34 selected cells for the treatment of poor graft function after allogeneic stem cell transplantation
P478volume20

Reverse relations

cites work (P2860)
Q98893607Advances in the understanding of poor graft function following allogeneic hematopoietic stem-cell transplantation
Q34413233Alpha/beta T-cell depleted grafts as an immunological booster to treat graft failure after hematopoietic stem cell transplantation with HLA-matched related and unrelated donors
Q95661285Conditioning regimen for allogeneic bone marrow transplantation in children with acquired bone marrow failure: fludarabine/melphalan vs. fludarabine/cyclophosphamide
Q91212144Eltrombopag for post-transplant cytopenias due to poor graft function
Q52780773Fresh or Cryopreserved CD34+-Selected Mobilized Peripheral Blood Stem and Progenitor Cells for the Treatment of Poor Graft Function after Allogeneic Hematopoietic Cell Transplantation.
Q88560885Graft failure after allogeneic hematopoietic stem cell transplantation
Q38879870Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis
Q37327622Increased reactive oxygen species and exhaustion of quiescent CD34-positive bone marrow cells may contribute to poor graft function after allotransplants
Q64249488Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell Depletion
Q64983057Placenta-Derived Adherent Stromal Cell Therapy for Hematopoietic Disorders: A Case Study of PLX-R18.
Q41483852Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation.
Q40466615The bone marrow microenvironment is similarly impaired in allogeneic hematopoietic stem cell transplantation patients with early and late poor graft function.
Q96640810Therapy of posttransplant poor graft function with eltrombopag
Q58122392[Effects of CD34(+) selected stem cells for the treatment of poor graft function after allogeneic stem cell transplantation]

Search more.